20h
Preclinical Work Advancing with Plans to Select a Next-Generation Oral Small Molecule PTH1R Agonist to Accelerate Toward the Clinic Later This ...
Reports Q4 revenue $212,000, consensus $150,000. “Our Native Complex Platform continues to produce a deep pipeline of oral small molecule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback